Yale School of Medicine starting trials on new epilepsy treatment that uses smart technology
About one-third of people diagnosed with epilepsy are not able to get relief from treatments currently available. Now, researchers at Yale University School of Medicine and two other locations are beginning trials on a new and innovative treatment that uses smart technology.Source: WTNH News 8
What to Do About Aducanumab? Academic Memory Programs Brace for the Tough Questions
Academic medical centers are establishing committees and workgroups to develop standards and criteria for determining eligibility for the newly-approved and controversial Alzheimer's drug, aducanumab.Source: NeurologyToday
Storms like Elsa bring low-pressure systems that may cause migraines; Yale doctor talks advances in treating, prevention
Storms like Tropical Storm Elsa that hit Connecticut this week bring low-pressure systems that, for some, trigger migraine headaches. A Yale Medicine doctor who treats headaches joined us Friday to talk about the advances in treating and preventing migraines.Source: News 8
$3.59M NIMH Grant Awarded to Serena Spudich, MD
A new, five-year, $3.59M grant from the National Institute of Mental Health (NIMH) was awarded to Principal Investigator Serena Spudich, MD, Gilbert Glaser Professor of Neurology at Yale, along with co-PI, Joshua Cyktor, PhD, of the University of Pittsburgh.
Bedside point-of-care MRI appears convenient and accurate
In one of the first deployments of a point-of-care MRI scanner, Dr. Kevin Sheth of Yale School of Medicine discussed the application of low-field POC MRI, outlining the constraints of conventional MRI and advantages of MRI at the bedside.Source: AuntMinnie.com
AAN 2021 Virtual Annual Meeting: Highlights
Each year, the American Academy of Neurology (AAN) hosts a meeting wherein neurologists nationwide convene to present on their latest research findings and to learn from their peers. The following members of Yale Neurology presented abstracts at the 2021 virtual annual meeting:
PATHS helps students from underrepresented backgrounds realize med school dreams
Nelson Perez Catalan discovered he was interested in pursuing science while working at a student job at the University of Oregon cleaning glass in the labs. He found himself drawn to research around the brain, and thought about pursuing an MD/PhD, but there was no medical school at his university and as a transplant from Chile, he says much of the U.S. college process was mystifying to him. Then he learned about PATHS, or Program to Advance Training in Health and Sciences at Yale School of Medicine.
CELLO Study to Explore Early Treatment of Multiple Sclerosis
Yale University announced today the initiation of a multicenter study aimed at treating early stage multiple sclerosis (MS). Supported by and in collaboration with Genentech, a member of the Roche Group, the study, known as “CELLO,” will investigate whether short-term treatment with ocrelizumab in patients with MRI lesions consistent with early MS without clinical disease—known as radiologic isolated syndrome—prevents the onset of symptoms.
A new treatment may halt cluster headaches. But some say psychedelic drugs are the real answer.
There are few successful treatment options for cluster headache, a rare, misunderstood, and intensely painful neurologic condition. However, new research suggests that psychedelic drugs may provide relief.Source: The Washington Post
Chronic Headache Disorders & Toxic Exposure: A Policy Panel Discussion
Right now, over 230,000 veterans have joined VA’s Airborne Hazards and Open Burn Pit Registry which documents self-reported health impacts. While much is still unknown, veterans exposed to burn pits report unexplained chronic illnesses, cancers, and respiratory conditions. For many veterans, that means living with debilitating headaches and chronic migraines. Currently, over one million veterans seeking care at VA are diagnosed with a headache disorder and 22 percent of veterans deployed with duties involving burn pits report functional limitations due to migraines. We have a responsibility to care for all those who have borne the battle-- we cannot leave these veterans behind. I’ve made addressing toxic exposure a top priority this Congress, and I am committed to moving forward comprehensive legislation to ensure all of our veterans exposed to toxic substances during their service can access the care and benefits they’ve earned—regardless of where or when they served.Source: Headache & Migraine Policy Forum